Leerink Partners Upgrades Halozyme Therapeutics (HALO) to Market Perform
Go back to Leerink Partners Upgrades Halozyme Therapeutics (HALO) to Market Perform| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 105.35 -1.57 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.92 | 52 Week High | $18.39 | |||
| Open | $106.45 | 52 Week Low | $6.96 | |||
| Day High | $106.81 | P/E | N/A | |||
| Day Low | $104.70 | EPS | $-0.58 | |||
| Volume | 1,681,930 | |||||
